期刊文献+

去铁胺对T淋巴细胞体外增殖、活化以及细胞周期的影响

Effect of defetoxamine on proliferation,activation and cell cycle of T lymphocytes
下载PDF
导出
摘要 分别采用MTT法、CFSE染色结合流式细胞术、双色荧光抗体染色结合流式细胞术、PI染色法检测去铁胺(DFO)对小鼠T淋巴细胞的药物毒性、对T淋巴细胞增殖、对Con A刺激下的小鼠T细胞CD69表达和淋巴细胞周期的影响。研究结果表明:DFO对淋巴细胞的毒性T细胞体外增殖、活化和细胞周期无影响;不同浓度的DFO(5、10、20、40μmol/L)能显著抑制受Con A刺激48 h和72 h后的T淋巴细胞增殖;低浓度的DFO(5、10μmol/L)对小鼠T淋巴细胞CD69的表达没有影响,高浓度(20、40μmol/L)的DFO可抑制T淋巴细胞CD69的表达;Ph能将T淋巴细胞抑制在G0/G1期。说明DFO除可通过抑制T淋巴细胞活化外,可能还通过其他机制抑制T淋巴细胞增殖,且DFO可以将淋巴细胞周期抑制在G0/G1期,可望发展成为一种新的免疫抑制干预药物。 In this paper, the cytotoxiciy of DFO to lymphocytes was evaluated using MTT assay, carboxyfluorescein diacetatesuccinimidyl ester (CFDA-SE) staining plus flow cytometry assay was employed to investigate the effect of DFO on the proliferation of the lymphocytes, the expression levels of CD69 on T lymphocytes stimulated by Con A were evaluated with flow cytometry after staining with fluorescent monoclonal antibody, and Cell-cycle distribution of T lymphocytes was also analyzed by propidium iodide staining. The results showed that DFO induced-cytotoxicity had little impact on the reliability of our experiment data; DFO (5,10,20,40 μmol/L) significantly inhibited the proliferation of T lymphocytes stimulated by Con A for 48 h and 72 h;DFO at low concentrations (5,10 μmol/L ) exerted no influence on the expression of CD69, however, DFO at high concentration (20, 40 μmol/L ) could inhibit the expression of CD69. The cell cycle distribution analysis revealed that DFO could induce a cell cycle arrest in G0/G1 phase. We can draw conclusion that DFO may use other mechanism except the inhibition of activation of T lymphocyte, to inhibit the proliferation of lymphocyte, it can induce a cell cycle arrest in G0/G1 phase. This effect demonstrates that DFO has the potential to be developed into a new immuo-intervention drug.
出处 《广东农业科学》 CAS CSCD 北大核心 2012年第16期165-168,共4页 Guangdong Agricultural Sciences
基金 国家"973"计划项目(2006CB504201 2004CB720100) 国家自然科学基金(30500466) 广东省自然科学基金(5300419) 广东省主体科研机构创新能力建设专项"华南农业基因研究与创新平台建设"(2011)
关键词 去铁胺 淋巴细胞 流式细胞术 抑制作用 defetoxamine lymphocyte flow cytometry inhibition
  • 相关文献

参考文献14

  • 1Hartley A, Davies M, Rice-Evans C. Desferrioxanline as a lipid chain-breaking antioxidant in sickle erythrocyte membranes[J]. FEBS Lett, 1990, 264(1):145-148. 被引量:1
  • 2Taher A, Aoun E, Sharara, et al. Five year trial of deferiprone chelation therapy in thalassaemia major patients [J].Aeta Haematol,2004, 112(4):179-183. 被引量:1
  • 3Dayani P N, Bishop M C, Black K, et al. Desferoxamine (DFO)-mediated iron chelation: rationale for a novel approach to therapy for brain cancer[J].J Neurooncol,2004,6(3):367-377. 被引量:1
  • 4Brard L, Granai C O, Swamy N. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma[J]. Gynecol Oncol,2006,100:116-127. 被引量:1
  • 5Asbeck B S V, Georgiou N A, Bruggen T V D, et al. Anti- HIV effect of iron chelators: different mechanisms involved[J]. J Clin Virol, 2001, 20(3):141-147. 被引量:1
  • 6Munn C G, Markenson A L, Kapadia A, et al. Impaired T-ceil mitogen responses in some patients with thalassemia intermedia [J]. Thymus, 1981,3(2):119-127. 被引量:1
  • 7Kim B M, Chung H W. Desferrioxamine (DFO) induces apoptosis through the p38-caspase8-Bid-Bax pathway in PHA- stimulated human lymphocytes [J].Toxicol Appl Pharm, 2008,228 (1):24-31. 被引量:1
  • 8Jung Y S, Bae E Y, Chung N G, et al.Comparison of Immune Responses Induced by Deferoxamine and Deferasirox[J].Korean J Hematol,2008,43(3): 150-158. 被引量:1
  • 9Hunt N H, Fragonas J C. Effects of anti-oxidants on ornithinc decarboxy|ase in mitogenically -activated T lymphocytes [~l]. Biochim Biophys Acta,1992,1133(3):261-267. 被引量:1
  • 10Reyk D V, Sarel S, Hunt N.Inhibition of Lymphoproliferation by Three Novel Iron Chelators of the Pyridoxal and Salieyl Aldehyde Hydrazone Classes [J]. Bioehem Pharmacol, 2000,60(4): 581 587. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部